How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study: [letters]

Paul Collinson; Kari Pulkki; Janne Suvisaari; Jan Ravkilde; Ana Stavljenic-Rukavina; Angelika Hammerer-Lercher; Hannsjörg Baum; Marja P. van Dieijen-Visser; Päivi Laitinen

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study: [letters]

Paul Collinson, Kari Pulkki, Janne Suvisaari, Jan Ravkilde, Ana Stavljenic-Rukavina, Angelika Hammerer-Lercher, Hannsjörg Baum, Marja P. van Dieijen-Visser, Päivi Laitinen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig

Originalspråk	engelska
Tidskrift	Clinical Chemistry (Washington, DC)
Volym	54
Nummer	2
Sidor (från-till)	448-449
Antal sidor	2
ISSN	0009-9147
Status	Publicerad - 2008
MoE-publikationstyp	B1 Artikel i en vetenskaplig tidskrift

Citera det här

@article{3a6fe0a80e6c4edb93f7fea4219dbe70,

title = "How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study: [letters]",

author = "Paul Collinson and Kari Pulkki and Janne Suvisaari and Jan Ravkilde and Ana Stavljenic-Rukavina and Angelika Hammerer-Lercher and Hannsj{\"o}rg Baum and Dieijen-Visser, {Marja P. van} and P{\"a}ivi Laitinen",

year = "2008",

language = "English",

volume = "54",

pages = "448--449",

journal = "Clinical Chemistry (Washington, DC)",

issn = "0009-9147",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study

T2 - [letters]

AU - Collinson, Paul

AU - Pulkki, Kari

AU - Suvisaari, Janne

AU - Ravkilde, Jan

AU - Stavljenic-Rukavina, Ana

AU - Hammerer-Lercher, Angelika

AU - Baum, Hannsjörg

AU - Dieijen-Visser, Marja P. van

AU - Laitinen, Päivi

PY - 2008

Y1 - 2008

M3 - Article

SN - 0009-9147

VL - 54

SP - 448

EP - 449

JO - Clinical Chemistry (Washington, DC)

JF - Clinical Chemistry (Washington, DC)

IS - 2

ER -